25
Participants
Start Date
April 10, 2019
Primary Completion Date
January 11, 2022
Study Completion Date
January 11, 2022
Pemziviptadil (PB1046) Injection
Once-weekly subcutaneous injection
NYU Langone Health, New York
University of Rochester Medical Center, Rochester
Allegheny General Hospital, Pittsburgh
UPMC Presbyterian, Pittsburgh
Emory University, The Emory Clinic, Atlanta
University of Miami - Pulmonary Research Center, Miami
The Lindner Center for Research and Education at The Christ Hospital, Cincinnati
University of Cincinnati, Cincinnati
University of Iowa Hospitals and Clinics, Iowa City
University of Kansas Medical Center, Kansas City
INTEGRIS Baptist Medical Center, Oklahoma City
University of Texas Southwestern Medical Center, Dallas
University of California San Diego, La Jolla
University of California - Davis, Sacramento
Tufts Medical Center, Boston
Brigham and Women's Hospital, Boston
Lead Sponsor
PhaseBio Pharmaceuticals Inc.
INDUSTRY